WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Up 677.8% in May

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWYGet Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 178,900 shares, a growth of 677.8% from the May 15th total of 23,000 shares. Based on an average trading volume of 75,100 shares, the short-interest ratio is currently 2.4 days.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft raised WuXi Biologics (Cayman) to a “buy” rating in a report on Thursday, March 27th.

Get Our Latest Analysis on WXXWY

WuXi Biologics (Cayman) Stock Up 4.9%

Shares of WXXWY stock opened at $7.09 on Friday. The stock has a 50 day simple moving average of $5.78 and a 200-day simple moving average of $5.41. WuXi Biologics has a 1-year low of $2.58 and a 1-year high of $7.30.

WuXi Biologics (Cayman) Company Profile

(Get Free Report)

WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC.

Featured Articles

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.